Four Asean nations among 38 to get Avigan drug from Japan for clinical trial

  • Japan
  • Wednesday, 29 Apr 2020

BANGKOK (The Nation/ANN): Japan is preparing to send Avigan, a drug used for treating influenza, to 38 countries this week, with four Asean countries -- the Philippines, Malaysia, Indonesia and Myanmar -- joining the trial for Covid-19 patients.

Japan's Minister for Foreign Affairs Toshimitsu Motegi said that Avigan, also known as Favipiravir, would be dispatched this week free of charge to be used in experiments to treat patients with Covid-19.

"The drug is effective in treating patients with Covid-19, especially in people with mild symptoms," added Motegi.

Motegi said Japan would work with countries receiving the drug to expand clinical research on the efficacy of treating patients with Covid-19

.Japan will also give US$1 million to the United Nations to buy and deliver the medicine to the countries in need.- The Nation/Asia News Network

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

Asean , Avigan , Japan , clinical , trials , free , drug , Favipiravir


Did you find this article insightful?


89% readers found this article insightful

Next In Regional

Covid-19: Cases up by 3,680, bringing total to 194,114 (updated daily)
Petronas named most valuable Asean brand for 2021
Malaysia's first Covid-19 vaccine trial officially underway
Survey: Chinese people increasingly alarmed over use of facial recognition for everything from refuse collection to toilet roll dispensers
Pony Ma is now China’s second-richest man as Tencent nears trillion-dollar club
Ex-deputy CM Liew wins defamation suit against planter
Ringgit to perform in 2021 despite short-term headwinds
Mobile use in Indonesia tops five hours a day
FAQ: Air travel during MCO 2.0
Kuaishou has changed the lives of millions in China, but will the short video app prove a good investment?

Stories You'll Enjoy